| ▲ | ceejayoz 6 hours ago | ||||||||||||||||
> Also what would be the bad outcomes here? If those drugs end up not being safe (that is prevented by the requirement to not withhold safety data), or being effective? Barring a time machine, safety data reporting is gonna lag at least some of the bad outcomes. | |||||||||||||||||
| ▲ | niklas_anzinger 6 hours ago | parent [-] | ||||||||||||||||
That is the same with all post-market monitoring for drugs. And maybe we can do better because more nimble/startup approach in a small state | |||||||||||||||||
| |||||||||||||||||